Paper Status Tracking
Contact us
[email protected]
Click here to send a message to me 3275638434
Paper Publishing WeChat

Article
Affiliation(s)

ABSTRACT

Two methods are described for the stability indicating determination of Atracurium Besylate in presence of its major degradant (Laudanosine). The first method was based on reversed liquid chromatography, C18 column (150 mm × 4.5 mm, 5 μm packing) was used for separation. The mobile phase consisted of a mixture of 0.075 M potassium dihydrogen: methanol: acetonitrile adjusted to a pH of 3.1 ± 0.2 with o-phosphoric acid (50:30:20, by volume). Flow rate of 1.0 mL/min was applied. Quantitation was achieved with UV detection at 280 nm. Linearity, accuracy and precision were found to be acceptable over the concentration range of (1-8 μg/mL) atracurium besylate (ATR). The second method was based on the thin layer chromatography (TLC) separation of the two drugs followed by densitometric measurements of their spots at 282 nm. The separation was carried out on silica gel plates using methanol: ethyl acetate (3:7, v/v) as developing system. The linear regression analysis data were used for the regression line in the range (2-18 μg/mL) of ATR. The two proposed methods were successfully applied to the determination of ATR in presence of LDS in laboratory prepared mixtures and in commercial vials. The optimized methods proved to be accurate, precise, highly selective and highly sensitive.

KEYWORDS

Reversed phase chromatography, TLC densitometry, atracurium besylate (ATR), degradation product, laudanosine (LDS).

Cite this paper

Ma’mun, A., et al. 2020. “Comparative Study for Determination of Atracurium Besilate in Presence of Its Toxic Degradant (Laudanosine) by Reversed Phase HPLC and by TLC Densitometry.” Journal of Pharmacy and Pharmacology 8 (9): 270-280.

References

About | Terms & Conditions | Issue | Privacy | Contact us
Copyright © 2001 - David Publishing Company All rights reserved, www.davidpublisher.com
3 Germay Dr., Unit 4 #4651, Wilmington DE 19804; Tel: 001-302-3943358 Email: [email protected]